Hypoxanthine is a pharmacodynamic marker of ischemic brain edema modified by glibenclamide

Hannah J. Irvine, Animesh Acharjee, Zoe Wolcott, Zsuzsanna Ament, H. E. Hinson, Bradley J. Molyneaux, J. Marc Simard, Kevin N. Sheth, W. Taylor Kimberly

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Hypoxanthine is a pharmacodynamic marker of ischemic brain edema modified by glibenclamide'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds